

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mesenchymal-epithelial cell signaling (GO:0060638) | 8.66530505 |
| 2 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 8.05427148 |
| 3 | positive regulation of DNA biosynthetic process (GO:2000573) | 7.98573926 |
| 4 | complement activation, classical pathway (GO:0006958) | 7.93928183 |
| 5 | negative regulation of response to reactive oxygen species (GO:1901032) | 7.31701227 |
| 6 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 7.09504687 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.82194170 |
| 8 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 6.73481556 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.64135061 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.37195004 |
| 11 | complement activation (GO:0006956) | 6.15730253 |
| 12 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 6.11449523 |
| 13 | positive regulation of respiratory burst (GO:0060267) | 6.04350387 |
| 14 | glomerular filtration (GO:0003094) | 4.82843153 |
| 15 | antibacterial humoral response (GO:0019731) | 4.38517693 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.37398876 |
| 17 | antimicrobial humoral response (GO:0019730) | 4.36483594 |
| 18 | protein activation cascade (GO:0072376) | 4.31320509 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 4.30353780 |
| 20 | renal filtration (GO:0097205) | 4.20857576 |
| 21 | humoral immune response (GO:0006959) | 4.16810668 |
| 22 | mitochondrion distribution (GO:0048311) | 4.15265344 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12460015 |
| 24 | regulation of respiratory burst (GO:0060263) | 4.06298900 |
| 25 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.95047151 |
| 26 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.95047151 |
| 27 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.95047151 |
| 28 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.92111131 |
| 29 | detection of bacterium (GO:0016045) | 3.89869881 |
| 30 | retina homeostasis (GO:0001895) | 3.81987634 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.79981866 |
| 32 | mitochondrial calcium ion transport (GO:0006851) | 3.74900958 |
| 33 | GDP-mannose metabolic process (GO:0019673) | 3.73197718 |
| 34 | detection of other organism (GO:0098543) | 3.71251802 |
| 35 | B cell mediated immunity (GO:0019724) | 3.66502144 |
| 36 | negative regulation of cell killing (GO:0031342) | 3.66170889 |
| 37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.66170889 |
| 38 | regulation of cellular extravasation (GO:0002691) | 3.59837448 |
| 39 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042) | 3.59132976 |
| 40 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.53729327 |
| 41 | regulation of DNA biosynthetic process (GO:2000278) | 3.52372265 |
| 42 | regulation of response to reactive oxygen species (GO:1901031) | 3.48119449 |
| 43 | negative regulation of oxidative stress-induced cell death (GO:1903202) | 3.43830294 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38374781 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36156125 |
| 46 | NADH metabolic process (GO:0006734) | 3.33660945 |
| 47 | negative regulation of cellular response to oxidative stress (GO:1900408) | 3.28719073 |
| 48 | negative regulation of response to oxidative stress (GO:1902883) | 3.28719073 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 3.25440623 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.18006121 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.18006121 |
| 52 | myeloid dendritic cell differentiation (GO:0043011) | 3.12410008 |
| 53 | response to type I interferon (GO:0034340) | 3.11673075 |
| 54 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.07149646 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04996854 |
| 56 | production of molecular mediator of immune response (GO:0002440) | 2.96626361 |
| 57 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.94663940 |
| 58 | positive chemotaxis (GO:0050918) | 2.92247440 |
| 59 | negative regulation of mitochondrion organization (GO:0010823) | 2.91777794 |
| 60 | hyaluronan metabolic process (GO:0030212) | 2.91432041 |
| 61 | germinal center formation (GO:0002467) | 2.89269641 |
| 62 | T-helper 1 type immune response (GO:0042088) | 2.88685055 |
| 63 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85741517 |
| 64 | proline biosynthetic process (GO:0006561) | 2.85148132 |
| 65 | cellular response to interferon-gamma (GO:0071346) | 2.82272880 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81147137 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 2.77550675 |
| 68 | detection of external biotic stimulus (GO:0098581) | 2.74929784 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.74160755 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71577389 |
| 71 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.70727377 |
| 72 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.69120283 |
| 73 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.67891362 |
| 74 | response to interleukin-4 (GO:0070670) | 2.65965916 |
| 75 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.63997715 |
| 76 | glycine transport (GO:0015816) | 2.60081737 |
| 77 | endothelial tube morphogenesis (GO:0061154) | 2.56511392 |
| 78 | morphogenesis of an endothelium (GO:0003159) | 2.56511392 |
| 79 | cellular response to interleukin-4 (GO:0071353) | 2.55961835 |
| 80 | negative regulation of myotube differentiation (GO:0010832) | 2.52954252 |
| 81 | response to interferon-gamma (GO:0034341) | 2.52104367 |
| 82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50058730 |
| 83 | regulation of protein heterodimerization activity (GO:0043497) | 2.48523431 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47964330 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47964330 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.47964330 |
| 87 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47964330 |
| 88 | modulation by symbiont of host defense response (GO:0052031) | 2.47964330 |
| 89 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47964330 |
| 90 | B cell homeostasis (GO:0001782) | 2.46950568 |
| 91 | peptidyl-arginine methylation (GO:0018216) | 2.46256076 |
| 92 | peptidyl-arginine N-methylation (GO:0035246) | 2.46256076 |
| 93 | negative regulation of B cell apoptotic process (GO:0002903) | 2.45642213 |
| 94 | cellular response to interferon-beta (GO:0035458) | 2.45205355 |
| 95 | regulation of cellular response to oxidative stress (GO:1900407) | 2.43503865 |
| 96 | negative T cell selection (GO:0043383) | 2.42798266 |
| 97 | defense response to protozoan (GO:0042832) | 2.40477661 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.39712352 |
| 99 | response to hepatocyte growth factor (GO:0035728) | 10.2067996 |
| 100 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 10.2067996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20087964 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92827620 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.90830273 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.26294201 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25701490 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.16062591 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80853657 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31692315 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31155418 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18145967 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16360578 |
| 12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.15145981 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13435050 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.11853142 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.10557899 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06900533 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06671368 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98373316 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98159826 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93480392 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82098502 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81348370 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78484647 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.75755019 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.75278319 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71278541 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70118784 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69813374 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69144622 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69141048 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66816666 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64866452 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.59723299 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59661501 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59150818 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58653128 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55475341 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55259746 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52539334 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51757244 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51420300 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49386644 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45417944 |
| 44 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43249144 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42856613 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42558093 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39985311 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39021103 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37725415 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37166280 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36701188 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33937013 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33490916 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32054447 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30453140 |
| 56 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29443337 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28706635 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28634969 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26260179 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23485070 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18473759 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18358297 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14449629 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13751204 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13690945 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12646607 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07831993 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07747830 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07657740 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07178626 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06606628 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06283028 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05629386 |
| 74 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04152659 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02626967 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01660395 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01219357 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01007266 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99976571 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99829561 |
| 81 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99648560 |
| 82 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99449002 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99308405 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99307240 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99044587 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98423147 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97907058 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97222238 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96844183 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96606957 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96478129 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96402262 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.96361055 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95697458 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94851776 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94006456 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.93650876 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93385690 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92282636 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92072221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.56386782 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.55372545 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.50167639 |
| 4 | MP0000685_abnormal_immune_system | 3.32950223 |
| 5 | MP0003303_peritoneal_inflammation | 3.25717817 |
| 6 | MP0003724_increased_susceptibility_to | 3.16832872 |
| 7 | MP0001790_abnormal_immune_system | 3.13756609 |
| 8 | MP0005387_immune_system_phenotype | 3.13756609 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.92908882 |
| 10 | MP0001800_abnormal_humoral_immune | 2.79798158 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.69453008 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.59016832 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.58234235 |
| 14 | MP0005671_abnormal_response_to | 2.48577324 |
| 15 | MP0003436_decreased_susceptibility_to | 2.47029480 |
| 16 | MP0005025_abnormal_response_to | 2.35942087 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.30430823 |
| 18 | MP0001873_stomach_inflammation | 2.24094467 |
| 19 | MP0003866_abnormal_defecation | 2.22450175 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.18917169 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.15032167 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.14081082 |
| 23 | MP0002723_abnormal_immune_serum | 2.10602957 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.08366057 |
| 25 | MP0005310_abnormal_salivary_gland | 2.03151829 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.03025054 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 2.01981318 |
| 28 | MP0001819_abnormal_immune_cell | 2.01836706 |
| 29 | MP0000490_abnormal_crypts_of | 1.80607754 |
| 30 | MP0009785_altered_susceptibility_to | 1.73555923 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.70464147 |
| 32 | MP0002398_abnormal_bone_marrow | 1.69934254 |
| 33 | MP0002006_tumorigenesis | 1.69055735 |
| 34 | MP0000716_abnormal_immune_system | 1.64365493 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.63417886 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.62091239 |
| 37 | MP0006082_CNS_inflammation | 1.60605627 |
| 38 | MP0002419_abnormal_innate_immunity | 1.59493864 |
| 39 | MP0005166_decreased_susceptibility_to | 1.57860105 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.55304403 |
| 41 | MP0002429_abnormal_blood_cell | 1.50739246 |
| 42 | MP0010307_abnormal_tumor_latency | 1.43384148 |
| 43 | MP0004947_skin_inflammation | 1.42275223 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.37137473 |
| 45 | MP0002722_abnormal_immune_system | 1.37058483 |
| 46 | MP0002405_respiratory_system_inflammati | 1.35637838 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.33443755 |
| 48 | MP0001663_abnormal_digestive_system | 1.31827880 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.31116885 |
| 50 | MP0002796_impaired_skin_barrier | 1.29687526 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.24934917 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.17385031 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.15048126 |
| 54 | MP0000477_abnormal_intestine_morphology | 1.13985265 |
| 55 | MP0000858_altered_metastatic_potential | 1.13414524 |
| 56 | MP0003045_fibrosis | 1.10244771 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.08828892 |
| 58 | MP0008004_abnormal_stomach_pH | 1.03264557 |
| 59 | MP0005451_abnormal_body_composition | 1.01904468 |
| 60 | MP0008469_abnormal_protein_level | 1.00396652 |
| 61 | MP0000470_abnormal_stomach_morphology | 1.00297700 |
| 62 | MP0004510_myositis | 0.98710343 |
| 63 | MP0000613_abnormal_salivary_gland | 0.97136542 |
| 64 | MP0000609_abnormal_liver_physiology | 0.96205749 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.95920395 |
| 66 | MP0003448_altered_tumor_morphology | 0.85289494 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 0.84251979 |
| 68 | MP0000343_altered_response_to | 0.83667970 |
| 69 | MP0010094_abnormal_chromosome_stability | 0.83322577 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.82690588 |
| 71 | MP0001853_heart_inflammation | 0.82396186 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.82337945 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.80727536 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.80551855 |
| 75 | MP0000681_abnormal_thyroid_gland | 0.78381018 |
| 76 | MP0000747_muscle_weakness | 0.77661687 |
| 77 | MP0003075_altered_response_to | 0.77044627 |
| 78 | MP0009278_abnormal_bone_marrow | 0.75856708 |
| 79 | MP0002163_abnormal_gland_morphology | 0.73932518 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.73556799 |
| 81 | MP0001730_embryonic_growth_arrest | 0.73387892 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.72742651 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.70299656 |
| 84 | MP0004858_abnormal_nervous_system | 0.70153856 |
| 85 | MP0002009_preneoplasia | 0.67613717 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.67246669 |
| 87 | MP0005501_abnormal_skin_physiology | 0.66475290 |
| 88 | MP0005670_abnormal_white_adipose | 0.65662374 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.65133999 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.64868830 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63688171 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.63467491 |
| 93 | MP0009931_abnormal_skin_appearance | 0.62839263 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.62617015 |
| 95 | MP0002132_abnormal_respiratory_system | 0.61060615 |
| 96 | MP0000313_abnormal_cell_death | 0.59449181 |
| 97 | MP0002060_abnormal_skin_morphology | 0.58092453 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57804172 |
| 99 | MP0005390_skeleton_phenotype | 0.57286715 |
| 100 | MP0001851_eye_inflammation | 0.56859591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 4.69041963 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.37499970 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.25870625 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.13514929 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.11679847 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.05048140 |
| 7 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.02833366 |
| 8 | Colitis (HP:0002583) | 3.76109567 |
| 9 | Vasculitis (HP:0002633) | 3.73803557 |
| 10 | Urticaria (HP:0001025) | 3.73682763 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.72021700 |
| 12 | Meningitis (HP:0001287) | 3.71793179 |
| 13 | Abnormality of T cell physiology (HP:0011840) | 3.56654475 |
| 14 | Prostate neoplasm (HP:0100787) | 3.40265159 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.35977884 |
| 16 | Villous atrophy (HP:0011473) | 3.28802827 |
| 17 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.28802827 |
| 18 | Esophageal neoplasm (HP:0100751) | 3.24639385 |
| 19 | Neoplasm of head and neck (HP:0012288) | 3.24639385 |
| 20 | Cellulitis (HP:0100658) | 3.23394583 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.19334913 |
| 22 | Increased IgE level (HP:0003212) | 3.09914903 |
| 23 | Recurrent viral infections (HP:0004429) | 3.09412877 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.09134193 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.09078547 |
| 26 | Skin rash (HP:0000988) | 3.05246053 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.04744566 |
| 28 | Lymphopenia (HP:0001888) | 3.03437456 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.99531883 |
| 30 | Rhabdomyolysis (HP:0003201) | 2.97487710 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.92190713 |
| 32 | Emphysema (HP:0002097) | 2.80052580 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.79660602 |
| 34 | Abnormality of T cells (HP:0002843) | 2.75511323 |
| 35 | Hyperparathyroidism (HP:0000843) | 2.74654538 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71776265 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71776265 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.68427374 |
| 39 | Chronic diarrhea (HP:0002028) | 2.58392664 |
| 40 | Osteomyelitis (HP:0002754) | 2.57183739 |
| 41 | Abnormality of the prostate (HP:0008775) | 2.55867649 |
| 42 | Obstructive lung disease (HP:0006536) | 2.54254555 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54254555 |
| 44 | Bronchitis (HP:0012387) | 2.52056226 |
| 45 | Ketoacidosis (HP:0001993) | 2.50465772 |
| 46 | Recurrent skin infections (HP:0001581) | 2.49507961 |
| 47 | Malnutrition (HP:0004395) | 2.48096157 |
| 48 | Premature loss of primary teeth (HP:0006323) | 2.47519915 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.44357712 |
| 50 | Increased IgM level (HP:0003496) | 2.44313785 |
| 51 | Verrucae (HP:0200043) | 2.39600141 |
| 52 | Papilloma (HP:0012740) | 2.39600141 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 2.35550736 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.35454272 |
| 55 | Ragged-red muscle fibers (HP:0003200) | 2.33434740 |
| 56 | Chronic otitis media (HP:0000389) | 2.33233105 |
| 57 | Abnormality of the nasal mucosa (HP:0000433) | 2.32109864 |
| 58 | IgM deficiency (HP:0002850) | 2.30163374 |
| 59 | B lymphocytopenia (HP:0010976) | 2.27817217 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.27327364 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.27295613 |
| 62 | Hyperactive renin-angiotensin system (HP:0000841) | 2.27158630 |
| 63 | Hypercortisolism (HP:0001578) | 2.24504368 |
| 64 | Granulocytopenia (HP:0001913) | 2.23832658 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.19549023 |
| 66 | Gingivitis (HP:0000230) | 2.18534349 |
| 67 | Acute hepatic failure (HP:0006554) | 2.16778798 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.15826725 |
| 69 | Abnormality of complement system (HP:0005339) | 2.15697532 |
| 70 | Sepsis (HP:0100806) | 2.14949484 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.13695941 |
| 72 | Hyperammonemia (HP:0001987) | 2.09432731 |
| 73 | Leukocytosis (HP:0001974) | 2.09102519 |
| 74 | Encephalitis (HP:0002383) | 2.08392827 |
| 75 | Restrictive lung disease (HP:0002091) | 2.07861846 |
| 76 | Hypermelanotic macule (HP:0001034) | 2.06300525 |
| 77 | Lymphoma (HP:0002665) | 2.04056959 |
| 78 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01751776 |
| 79 | Xerostomia (HP:0000217) | 2.00880652 |
| 80 | Abnormality of T cell number (HP:0011839) | 1.98569416 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98380979 |
| 82 | Skin ulcer (HP:0200042) | 1.97837951 |
| 83 | Trismus (HP:0000211) | 1.97556573 |
| 84 | Ridged nail (HP:0001807) | 1.97279071 |
| 85 | Nasal polyposis (HP:0100582) | 1.97030672 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 1.96324204 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 1.93420303 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93073151 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.93073151 |
| 90 | Myoglobinuria (HP:0002913) | 1.92085710 |
| 91 | Hemoptysis (HP:0002105) | 1.89023608 |
| 92 | Hypertensive crisis (HP:0100735) | 1.84845983 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.78120873 |
| 94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.77056658 |
| 95 | Purpura (HP:0000979) | 1.77052517 |
| 96 | IgA deficiency (HP:0002720) | 1.76659673 |
| 97 | Eosinophilia (HP:0001880) | 1.75523489 |
| 98 | Myositis (HP:0100614) | 1.74004059 |
| 99 | Hypokinesia (HP:0002375) | 1.73749747 |
| 100 | Orchitis (HP:0100796) | 1.69027806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.22131405 |
| 2 | ERN1 | 3.83271002 |
| 3 | PRPF4B | 3.70028850 |
| 4 | IRAK3 | 2.91432975 |
| 5 | IRAK4 | 2.71909590 |
| 6 | BLK | 2.61722910 |
| 7 | MAP4K1 | 2.48357859 |
| 8 | GRK6 | 2.37683755 |
| 9 | TYK2 | 2.24364058 |
| 10 | PIM2 | 2.03047474 |
| 11 | MAP3K14 | 1.99998898 |
| 12 | EPHA3 | 1.94280680 |
| 13 | BCKDK | 1.90230970 |
| 14 | TRIB3 | 1.89950503 |
| 15 | RIPK4 | 1.88795050 |
| 16 | FGFR4 | 1.87580338 |
| 17 | NEK1 | 1.81343813 |
| 18 | SMG1 | 1.74744771 |
| 19 | MAP3K13 | 1.68543629 |
| 20 | EEF2K | 1.61977661 |
| 21 | TBK1 | 1.55065854 |
| 22 | IKBKE | 1.54986153 |
| 23 | DAPK1 | 1.51835290 |
| 24 | SIK1 | 1.50583379 |
| 25 | SIK3 | 1.49733989 |
| 26 | IRAK1 | 1.44774034 |
| 27 | MAP2K3 | 1.38688579 |
| 28 | ICK | 1.34850918 |
| 29 | JAK3 | 1.29213617 |
| 30 | MAP3K1 | 1.27449688 |
| 31 | MAP3K8 | 1.27103442 |
| 32 | NME2 | 1.26864360 |
| 33 | CDK4 | 1.26193495 |
| 34 | KIT | 1.25448934 |
| 35 | FES | 1.24664866 |
| 36 | MAPK11 | 1.09627477 |
| 37 | JAK1 | 1.06951978 |
| 38 | JAK2 | 1.06327993 |
| 39 | CDC42BPA | 1.05319550 |
| 40 | EPHB1 | 1.05283119 |
| 41 | LYN | 1.03623476 |
| 42 | TXK | 0.97891474 |
| 43 | IRAK2 | 0.97466649 |
| 44 | EIF2AK1 | 0.97137774 |
| 45 | IKBKB | 0.96744182 |
| 46 | PIM1 | 0.94130175 |
| 47 | STK10 | 0.93283133 |
| 48 | BUB1 | 0.92921191 |
| 49 | NME1 | 0.91618958 |
| 50 | RAF1 | 0.91575985 |
| 51 | CSK | 0.91412519 |
| 52 | RIPK1 | 0.89286816 |
| 53 | FGFR3 | 0.89219940 |
| 54 | MAP2K2 | 0.87717464 |
| 55 | ARAF | 0.83830146 |
| 56 | TESK2 | 0.83525800 |
| 57 | TAOK2 | 0.83080390 |
| 58 | KSR2 | 0.83077436 |
| 59 | MAPKAPK2 | 0.82813282 |
| 60 | TAOK1 | 0.82358365 |
| 61 | MST1R | 0.80251470 |
| 62 | SYK | 0.79519592 |
| 63 | ZAP70 | 0.76752040 |
| 64 | KDR | 0.70953005 |
| 65 | PRKD2 | 0.70942948 |
| 66 | PIK3CA | 0.70108950 |
| 67 | BTK | 0.66253477 |
| 68 | MAPK4 | 0.66099300 |
| 69 | STK4 | 0.65301591 |
| 70 | HCK | 0.64725335 |
| 71 | AURKA | 0.58989384 |
| 72 | MAP3K3 | 0.58419587 |
| 73 | BRAF | 0.57698794 |
| 74 | MAP3K11 | 0.56088286 |
| 75 | TNK2 | 0.55921702 |
| 76 | MAPK12 | 0.54417716 |
| 77 | MARK3 | 0.54145997 |
| 78 | LMTK2 | 0.53487629 |
| 79 | CDC7 | 0.53070639 |
| 80 | RPS6KA5 | 0.51716687 |
| 81 | EPHB2 | 0.49851520 |
| 82 | ALK | 0.49840098 |
| 83 | TTN | 0.47989869 |
| 84 | NLK | 0.47978626 |
| 85 | MAPK7 | 0.46249623 |
| 86 | OBSCN | 0.46175617 |
| 87 | LCK | 0.45400659 |
| 88 | CSF1R | 0.40865280 |
| 89 | PASK | 0.40654074 |
| 90 | CDK8 | 0.39963528 |
| 91 | TGFBR1 | 0.39612545 |
| 92 | DMPK | 0.38359271 |
| 93 | AURKB | 0.37686667 |
| 94 | DAPK3 | 0.35714951 |
| 95 | MATK | 0.34761772 |
| 96 | PDPK1 | 0.34150681 |
| 97 | HIPK2 | 0.33671704 |
| 98 | LRRK2 | 0.32654952 |
| 99 | SCYL2 | 0.31645888 |
| 100 | CDK7 | 0.30966443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.09111661 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.71766577 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.60422698 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.57532989 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.32805138 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.08052211 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.79849547 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54016927 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52175833 |
| 10 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.51352707 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.47101846 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.39442678 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28248730 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23314425 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98117558 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75709733 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.74767335 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72905335 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66043448 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61489952 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52130091 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42397863 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34363063 |
| 24 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.30810731 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29706803 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.26161397 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.25525089 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24705512 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23625583 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20743163 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14440618 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14107275 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.10424240 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05464203 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05218215 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04228359 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03971741 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99034803 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96688435 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93553852 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90465426 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88024773 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86078035 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85561220 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.83135616 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81392484 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79930209 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79793211 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79693895 |
| 50 | Alcoholism_Homo sapiens_hsa05034 | 0.78728804 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77915582 |
| 52 | Measles_Homo sapiens_hsa05162 | 0.76959654 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76291312 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76219785 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75716955 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71490128 |
| 57 | Melanoma_Homo sapiens_hsa05218 | 0.71232693 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.71117151 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70709663 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68282116 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.67160886 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.64939303 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64703010 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.62910939 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61516378 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.61085429 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60029406 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58793040 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56580689 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.54080481 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49565439 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49418812 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.46710282 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45105760 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.44792804 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44245548 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43197558 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42321922 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41825366 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.40121655 |
| 81 | Base excision repair_Homo sapiens_hsa03410 | 0.38728580 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38249100 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34582910 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34562654 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33872816 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32771490 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31829704 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30736725 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28494921 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28432486 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.28175480 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28058981 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28010849 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26478172 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25663597 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25603906 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21883795 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20940010 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19412848 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.19308323 |

